Z Squared (ZSQR) AI Stock Analysis
Z Squared
(NASDAQ:ZSQR)
No summary available
Z Squared (ZSQR) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $191.86M
- Dividend Yield
- ―
- Average Volume (3M)
- 407.93K
- Price to Earnings (P/E)
- -2.0
- Beta (1Y)
- 0.72
- Revenue Growth
- 961.16%
- EPS Growth
- 58.59%
- Country
- US
- Employees
- 6
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Services
Z Squared Business Overview & Revenue Model
Company Description
Z Squared Inc. operates as an integrated computing infrastructure company, deploying and managing advanced computing equipment across its facilities in North Carolina, South Carolina, and Iowa. The firm diligently oversees and optimizes its extensive...
Z Squared Risk Analysis
Z Squared disclosed 26 risk factors in its most recent earnings report. Z Squared reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksZ Squared Peers Comparison
Overall Rating
PRLD53Neutral
RLMD48Neutral
HOWL47Neutral
ABVC43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 53Neutral | $309.64M | -4.91 | -75.35% | ― | 220.34% | 55.73% | |
| 48Neutral | $381.88M | -3.89 | -47.52% | ― | ― | 57.98% | |
| 47Neutral | $47.92M | -1.34 | -166.98% | ― | ― | 55.37% | |
| 43Neutral | $26.69M | -3.39 | -71.47% | ― | -100.00% | -55.90% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ZSQR | Z Squared Inc. | 3.59 | -11.84 | -76.73% | |
| RLMD | Relmada Therapeutics Inc | 3.58 | 1.38 | 62.73% | |
| ABVC | ABVC BioPharma, Inc. | 1.00 | -1.96 | -66.22% | |
| PRLD | Prelude Therapeutics, Inc. | 3.88 | -0.10 | -2.51% | |
| HOWL | Werewolf Therapeutics, Inc. | 0.99 | -0.32 | -24.73% | |
| ESLA | Estrella Immunopharma, Inc. | 0.64 | -2.41 | -79.05% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.